DFLV - ETF AI Analysis
Top Page
Dimensional US Large Cap Value ETF (DFLV)
DFLV, the Dimensional US Large Cap Value ETF, has a solid overall rating, largely supported by strong, diversified holdings like Johnson & Johnson, Meta Platforms, and Micron, which benefit from robust financial performance, positive earnings sentiment, and strategic growth in areas such as AI and healthcare. The fund’s rating is held back somewhat by weaker technical trends and specific challenges at holdings like Berkshire Hathaway, Chevron, and Procter & Gamble, and investors should be aware that exposure to large value-oriented U.S. companies can mean sensitivity to sector-specific issues and shifts in economic conditions.
DFLV vs. SPDR S&P 500 ETF (SPY)
- AUM
- 7.43B
- Region
- North America
- Expense Ratio
- 0.21%
- Beta
- 0.70
- Issuer
- Dimensional
- Inception Date
- Dec 06, 2022
- Dividend Yield
- 1.35%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
DFLV Summary
Dimensional US Large Cap Value ETF (DFLV) invests in big, established U.S. companies that the manager believes are currently priced cheaply compared with their business strength. It doesn’t track a set index, but follows a value-investing approach across many sectors like financials, health care, and energy. Well-known holdings include JPMorgan Chase, Amazon, and Exxon Mobil. Someone might invest in this ETF to seek long-term growth while spreading risk across many large companies. A key risk is that value stocks can stay out of favor for long periods, so the price can go up and down with the market and style trends.
How much will it cost me?
This ETF has an expense ratio of 0.21%, which means you’ll pay about $2.10 per year for every $1,000 invested. That cost is slightly higher than the cheapest index ETFs because this fund is actively managed, using a more hands-on, research-driven approach to pick large-cap value stocks.
What would affect this ETF?
DFLV could benefit if the U.S. economy stays healthy, interest rates stabilize or fall, and value stocks in sectors like financials, energy, and health care come back into favor, supporting major holdings such as JPMorgan, Exxon Mobil, and Johnson & Johnson. On the other hand, a U.S. slowdown, rising rates that pressure banks, weaker energy prices, or tighter regulations on big tech names like Amazon and Meta could weigh on returns for this U.S.-focused large-cap value fund.
DFLV Top 10 Holdings
DFLV is leaning hard into classic U.S. value stories, with big weights in financials and energy setting the tone. Exxon and Chevron have been the fund’s workhorses lately, rising on strong cash generation and firm energy markets. Berkshire Hathaway and Procter & Gamble add a steadier, defensive backbone, quietly helping performance without much drama. On the flip side, Amazon and Meta have been losing steam, acting as mild brakes rather than engines. Overall, this is a U.S.-only, large-cap value play with no single tech giant dominating the show.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 AMZN | Amazon | 4.66% | $345.29M | $2.59T | 7.85% | 71Outperform |
 JPM | JPMorgan Chase | 4.50% | $333.63M | $895.92B | 8.92% | 72Outperform |
 XOM | Exxon Mobil | 4.09% | $303.11M | $769.96B | 63.27% | 74Outperform |
 CVX | Chevron | 2.12% | $157.01M | $465.33B | 53.41% | 71Outperform |
 META | Meta Platforms | 2.06% | $152.55M | $1.57T | -7.72% | 76Outperform |
 BRK.B | Berkshire Hathaway B | 2.00% | $148.42M | $1.16T | 13.37% | 66Neutral |
 UNH | UnitedHealth | 1.60% | $118.42M | $365.29B | 18.05% | 72Outperform |
 GS | Goldman Sachs Group | 1.34% | $99.33M | $260.47B | 13.21% | 73Outperform |
 PG | Procter & Gamble | 1.32% | $97.57M | $374.48B | 8.02% | 69Neutral |
 LIN | Linde | 1.29% | $95.83M | $236.08B | 19.62% | 66Neutral |
DFLV Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DFLV, the sentiment is Positive. The current price of 41.81 is above the 20-day moving average (MA) of 41.31, above the 50-day MA of 41.28, and above the 200-day MA of 38.72, indicating a bullish trend. The MACD of 0.24 indicates Negative momentum. The RSI at 60.58 is Neutral, neither overbought nor oversold. The STOCH value of 86.68 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DFLV.
DFLV Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| DFLV | $41.81 | $45.00(7.63% Upside) | $7.43B | 0.21% | 73Outperform |
 JAVA | $82.96 | $96.49(16.31% Upside) | $7.46B | 0.44% | 71Outperform |
 FELV | $42.94 | $48.98(14.07% Upside) | $3.69B | 0.18% | 72Outperform |
 DSTL | $69.59 | $79.37(14.05% Upside) | $2.12B | 0.39% | 72Outperform |
 SEIV | $49.79 | $59.34(19.18% Upside) | $1.64B | 0.15% | 72Outperform |
 DUSA | $56.40 | $67.02(18.83% Upside) | $1.28B | 0.59% | 67Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DFLV | Dimensional US Large Cap Value ETF | 41.81 | 9.55 | 29.60% | |
| JAVA | JPMorgan Active Value ETF | 82.96 | 14.51 | 21.19% | |
| FELV | Fidelity Enhanced Large Cap Value ETF | 42.94 | 9.76 | 29.41% | |
| DSTL | Distillate US Fundamental Stability & Value ETF | 69.59 | 13.65 | 24.40% | |
| SEIV | SEI Enhanced U.S. Large Cap Value Factor ETF | 49.79 | 10.72 | 27.44% | |
| DUSA | Davis Select U.S. Equity ETF | 56.40 | 8.46 | 17.64% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.